Pleomorphism in high‑grade tumours
A pathology resident highlighted that high‑grade urothelial carcinoma typically shows marked nuclear pleomorphism alongside other features and often links to TP53 mutations, calling attention to the degree of nuclear variation on smears (x.com). The educational thread presented the morphologic pattern as a teaching point for recognizing high‑grade disease and appeared in a short viral post this week (x.com).
Pathologists grade many cancers by how abnormal the cells look, and one of the clearest warning signs is pleomorphism — nuclei that vary wildly in size and shape. In urothelial carcinoma, the main bladder cancer type, marked nuclear pleomorphism is a classic high-grade feature. (pathologyoutlines.com) Urothelial carcinoma starts in the lining of the urinary tract, most often the bladder. The American Cancer Society estimates 84,530 new bladder cancer cases and 17,870 deaths in the United States in 2026. (cancer.org) Under the microscope, “high grade” means the tumour cells have lost much of the orderly look of normal urothelium. Pathology references describe enlarged, dark, irregular nuclei, high nuclear-to-cytoplasmic ratios, frequent mitoses, and pleomorphism as the core pattern. (pathologyoutlines.com) That same pattern shows up in flat lesions as well as invasive disease. Urothelial carcinoma in situ, a noninvasive but high-grade lesion, is defined by severe nuclear atypia, including nuclear enlargement, hyperchromasia, and loss of polarity. (pathologyoutlines.com) The World Health Organization’s 2022 urinary tumour classification kept grade central to diagnosis and reporting in bladder cancer. The system also treats all histologic subtypes of urothelial carcinoma and tumours with divergent differentiation as high grade, even when some cells look deceptively bland. (publications.iarc.who.int) (pathologyoutlines.com) For trainees, pleomorphism is useful because it is visible on routine biopsy slides and urine cytology smears before any molecular test comes back. A 2024 study on automated image analysis noted that bladder tumour grade is still assigned from nuclear features such as size, hyperchromasia, and pleomorphism, and that those judgments can vary between observers. (springer.com) The molecular story partly overlaps with the microscopic one. Reviews of urothelial carcinoma describe TP53 alterations as common in high-grade disease, especially in genomically unstable pathways, but they also note that TP53 status alone does not define every tumour’s behaviour or treatment response. (pubmed.ncbi.nlm.nih.gov) (surgpath.theclinics.com) Grade is not the same thing as stage, which is how far a cancer has spread into the bladder wall or beyond. European Association of Urology guidelines separate non-muscle-invasive from muscle-invasive disease because treatment decisions depend on depth of invasion as well as high-grade morphology. (uroweb.org) That is why a short teaching post about pleomorphism can travel far outside pathology circles. One visual pattern — nuclei that no longer resemble one another — still anchors how doctors recognize high-grade urothelial carcinoma in daily practice. (pathologyoutlines.com)
